 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Education and Environment Promotion |
| Street 1: | Chowrangi Bazar, Haripur |
| Street 2: | |
| City: | Thakurgaon |
| Province: | |
| Post Code: | 5130 |
| Country: | Bangladesh |
| Phone: | +8801719531806 |
| Organization Email: | info@eep-bd.org |
| Web Site: | http://eep-bd.org |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Communities |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Community-Based Organization (CBO) |
| Organization Description: | |
| 1) Health, fitness and wellbeing of poor and marginalized people of the society. . 2) Bangladesh is a high burden country for Tuberculosis. In pursuance with End TB strategy we need to mobilize more resources and actions to control TB epidemic in this country. Our organization works in one of the backward areas of the country. In this particular area plenty of people are getting affected byTB. We think those people need support to be cured and come back to usual productive life. So our organization is interested to work for TB control and care in our area. 3) We have planned to gear up ACSM activity in our area to build awareness about Tuberculosis. We have also planned to support DOTS to ensure full adherence to treatment for TB and drug resistant TB. |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Civil Society and Community Engagement Research and Development Technical Assistance Working on Community, Rights and Gender (CRG) Working on Key Populations related to TB |
Other Organization Information | |
| Total number of staff in your organization: | 11 - 25 |
| Number of full-time staff who are directly involved with TB: | 1 - 5 |
| Number of part-time staff who are directly involved with TB: | 1 - 5 |
| Number of volunteers who are directly involved with TB: | 6 - 10 |
| How did you hear about the Stop TB Partnership: | Attendance at a TB related event |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | Bangladesh |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| We are providing support to TB patients in our area by helping them pursue DOTS and improving awareness about TB infection. We also undertook some research work with National TB control Program, Bangladesh. | |
Geographical Reach | |
| Which country is your headquarters located in: | Bangladesh |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Bangladesh |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB Care Delivery: In Bangladesh we plan to provide ACSM at DOTS centers to increase adherence to treatment, reduce drop out, IPT promotion and child TB care. Drug-Resistant TB: In Bangladesh we plan to promote shorter regimen of drugs, ambulatory management of cases, prevention of XDR, special intervention at high risk areas e.g. garments, prisons and slums. TB-HIV: We plan to examine all HIV cases for TB. Laboratory Strengthening: We plan to promote scaling up of Molecular test for all suspects of DR-TB. New Diagnostics: We plan to promote Gene Xpert at all DOT centers. New TB Drugs: WE plan to roll out shorter regimen of drugs for MDR- TB treatment. Research: We plan to undertake researches about drug resistance - its development, transmission and prevalence. . |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | June 13, 2016 |
| Last updated: | September 6, 2016 |